Nachrichten zur Amgen Aktie

Why Amgen (AMGN) Could Beat Earnings Estimates Again

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

How The Shutdown Impacts Healthcare

In this week’s edition of InnovationRx, we look at the Nobel Prize winners in medicine, Amgen’s direct-to-consumer effort, and more.…

Martin Capital Buys Into Portland General Electric’s Defensive Power Play

Key PointsMartin Capital Partners bought 109,347 shares of Portland General Electric in a new position, with an estimated transaction value…

Amgen (AMGN) Stock Sinks As Market Gains: Heres Why

Amgen (AMGN) reached $294.12 at the closing of the latest trading day, reflecting a -1.27% change compared to its last…

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock

Key PointsExited 51,431 shares in LyondellBasell Industries; estimated trade value of approximately $3.0 million, based on the average share price…

Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan

Key PointsMartin Capital sold 32,525 shares of Diageo, an estimated $3.28 million trade based on average pricing for the quarter…

Martin Capital Exits $5.8 Million Comcast Stake as Broadband Challenges Persist

Key PointsMartin Capital sold 162,125 shares of Comcast for an estimated $5.8 million in the third quarter.The transaction represented 2.2%…

Martin Capital Sells $3.6 Million in JPMorgan Stock — What to Know Ahead of Q3 Earnings

Key PointsMartin Capital sold 12,035 JPMorgan shares worth an estimated $3.6 million in the third quarter.The transaction value represented approximately…

Amgen to sell cholesterol drug at 60% discount direct to US consumers

Amgen on Monday launched direct-to-consumer U.S. sales of its cholesterol medication Repatha at a discounted cash price, becoming the latest…

Immatics Appoints Venkat Ramanan as Chief Financial Officer

Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical…

Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?

Amgen (AMGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…

Amgen: Ein attraktives Investment in einem unsicheren Markt

Inmitten der Turbulenzen an den Finanzmärkten suchen Anleger nach stabilen, aber dennoch wachstumsstarken Unternehmen. Die Aktie des Biopharma-Riesen Amgen (i)…

Amgen Stock Sinks As Market Eyes MariTides Next Move

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after…

Amgen: Solide Zahlen und ein Haar in der Suppe

Amgen hat mit seinen Quartalszahlen positiv überrascht und zugleich die Prognose für das Gesamtjahr 2025 angehoben. Dennoch rutschte die Aktie…

ROUNDUP: Amgen hebt Prognose an - Sorgen um MariTide drücken Kurs

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer…

ROUNDUP: Amgen hebt Prognose an - Sorgen um MariTide drücken Kurs

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer auf 2025. Der Umsatz…

Amgens Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly

Amgen posts strong Q2 beats on earnings and sales, driven by double-digit drug volume gains.…

Earnings call transcript: Amgen beats Q2 2025 earnings expectations By Investing.com

Earnings call transcript: Amgen beats Q2 2025 earnings expectations…

Amgen (AMGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter…

Amgen profit rises, weight-loss data expected in 4th quarter

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales offset…

Amgen hebt Prognose nach überraschend gut verlaufenem Quartal an

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer auf 2025. Der Umsatz…

Amgen hebt Prognose nach überraschend gut verlaufenem Quartal an

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer…

Amgen quarterly results beat Wall Street estimates

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales offset…

Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth

Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?

Is it a good or bad thing when a stock experiences a golden cross technical event?…

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know

Amgen (AMGN) reached $301.29 at the closing of the latest trading day, reflecting a -1.73% change compared to its last…

The Best High-Yield Dividend ETF to Own for the Next 10 Years

Key PointsCompanies must pass key tests to be included in the Schwab U.S. Dividend Equity ETF.This fund has averaged a…

Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?

AMGNs deep pipeline and rare disease expansion may outweigh NVOs GLP-1 dominance and leadership shakeup.…

Amgen (AMGN) Declines More Than Market: Some Information for Investors

In the latest trading session, Amgen (AMGN) closed at $294.76, marking a -1.17% move from the previous day.…

Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More

…

Dows 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares

The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…

Amgen: Great Starting Yield For This Wealth Compounder

…

How Does Nvidias Reaching $4 Trillion in Market Cap Impact the S&P 500, Nasdaq-100, and Dow Jones?

Key PointsNvidia became the first company to surpass $4 trillion in market cap.A handful of companies can move the Nasdaq-100…

Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Amgen (AMGN) closed at $295.18, marking a -1.73% move from the previous day.…

Amgen: A Defensive Biotech With Yield And Optionality

…

Amgen (AMGN) Advances While Market Declines: Some Information for Investors

Amgen (AMGN) closed the most recent trading day at $297, moving +1.38% from the previous trading session.…

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…

Amgen (AMGN) Outperforms Broader Market: What You Need to Know

The latest trading day saw Amgen (AMGN) settling at $296.85, representing a +2.18% change from its previous close.…

Why Amgen Stock Popped by 4% Today

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the…

2 Dividend Stocks to Buy on the Dip and Hold Forever

Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic…

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.…

Amgen (AMGN) Stock Moves 1.03%: What You Should Know

In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.…

Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript

…

Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Amgen (AMGN) closed at $272.44, marking a -5.84% move from the previous day.…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Members of Congress Are Pouring Millions Into These 7 Surprising Stocks

In this video, I will review some of the stock purchases made by members of the U.S. Congress. Politicians such…

Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?

Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical…

Amgen: Imdelltra Data And Q1 Results Impress

…

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Amgen (AMGN) closed at $297.29 in the latest trading session, marking a +1.88% move from the prior day.…

Amgen Inc. (AMGN) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…